Litcius/Paper detail

Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols?

Shelly Pathania, Pankaj Kumar Singh

2020Expert Opinion on Drug Metabolism & Toxicology79 citationsDOIOpen Access PDF

Abstract

(2021). Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? Expert Opinion on Drug Metabolism & Toxicology: Vol. 17, No. 4, pp. 351-354.

Topics & Concepts

MedicineDrugPharmacokineticsPharmacologyApproved drugIntensive care medicineDrug approvalCompliance (psychology)Risk analysis (engineering)PsychologySocial psychologyComputational Drug Discovery MethodsPharmacogenetics and Drug MetabolismBiosimilars and Bioanalytical Methods
Analyzing FDA-approved drugs for compliance of pharmacokinetic principles: should there be a critical screening parameter in drug designing protocols? | Litcius